Works matching IS 08909091 AND DT 2010 AND VI 24 AND IP 9
Results: 26
Metabolic syndrome after hormone-modifying therapy: risks associated with antineoplastic therapy.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Rare bladder tumors: caveat emptor.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Metabolic effects of hormone deprivation therapy: weighing the evidence.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Integrative oncology.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Considering metabolic effects when making breast cancer treatment decisions.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Solitary extramedullary and bone plasmacytomas versus multiple myeloma with extramedullary manifestation.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Solitary extramedullary plasmacytoma of the bladder: a case report and literature.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Intensity-modulated radiation therapy for anal cancer: an obvious yet complicated transition.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
The role, timing, and clinical use of ADT in prostate cancer.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Intensity-modulated radiation therapy for anal cancer: toxicity versus outcomes.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Cardiovascular risk associated with androgen deprivation therapy.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Androgen deprivation therapy in high-risk prostate cancer.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Androgen deprivation therapy: a survival benefit or detriment in men with high-risk prostate cancer?
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
INTEGRATIVE ONCOLOGY.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 851
- By:
- Publication type:
- Article
Metabolic Effects of Hormone Deprivation Therapy: Weighing the Evidence.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 846
- By:
- Publication type:
- Article
Considering Metabolic Effects When Making Breast Cancer Treatment Decisions.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 844
- By:
- Publication type:
- Article
Metabolic Syndrome After Hormone-Modifying Therapy: Risks Associated With Antineoplastic Therapy.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 839
- By:
- Publication type:
- Article
Rare Bladder Tumors: Caveat Emptor.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
Solitary Extramedullary and Bone Plasmacytomas versus Multiple Myeloma with Extramedullary Manifestation.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
Solitary Extramedullary Plasmacytoma of the Bladder: A Case Report and Literature.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Intensity-Modulated Radiation Therapy for Anal Cancer: An Obvious yet Complicated Transition.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 828
- By:
- Publication type:
- Article
The Role, Timing, and Clinical Use of ADT in Prostate Cancer.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 809
- By:
- Publication type:
- Article
Androgen Deprivation Therapy in High-Risk Prostate Cancer.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 806
- By:
- Publication type:
- Article
Cardiovascular Risk Associated With Androgen Deprivation Therapy.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 799
- By:
- Publication type:
- Article
Androgen Deprivation Therapy: A Survival Benefit or Detriment in Men With High-Risk Prostate Cancer?
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 790
- By:
- Publication type:
- Article
Intensity-Modulated Radiation Therapy for Anal Cancer: Toxicity versus Outcomes.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 9, p. 815
- By:
- Publication type:
- Article